To our knowledge, this is the first study to systematically investigate the factors affecting KL-6 levels; additionally, we developed a decision tree model to determine the presence of ILD among patients with CTD in the real world without the exclusion of patients with comorbidities. Here, MUC1 is linked to interstitial lung disease.